People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 receptor agonist. High-profile endorsements, including from Elon Musk, have ...

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

As medications like 'Wegovy' and 'Ozempic' (GLP‑1 receptor agonists) become more common in weight‑loss strategies, US ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

A WOMAN has revealed how shedding a whopping 8st completely transformed her life but also landed her in a major surgery. The weight loss warrior, Em, has been documenting her transformation on her ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...

Men were three times more likely than women to say GLP-1s boosted their confidence and two times more likely to say they were going on more dates. They also reported higher libido, more matches and ...

A new study reveals key predictors of successful weight loss on GLP-1RA drugs like Ozempic and Wegovy, including longer ...